World Health Organization SAGE Issues Interim Recommendations for Novavax COVID-19 Vaccine
– WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommends primary two-dose vaccination series of NVX-CoV2373 in persons aged 18 and older – SAGE recommends additional third dose of NVX-CoV2373 administered to immunocompromised persons – Recommendation follows grant of WHO Emergency Use Listing for Novavax’ vaccine Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and…